Knockout of the Staphylococcus aureus virulence gene sdrC promotes Myh7 expression to inhibit the progression of osteomyelitis
- PMID: 40471432
- DOI: 10.1007/s10735-025-10447-x
Knockout of the Staphylococcus aureus virulence gene sdrC promotes Myh7 expression to inhibit the progression of osteomyelitis
Abstract
The incidence of osteomyelitis has been increasing annually, but the specific molecular pathogenesis of Staphylococcus aureus-induced osteomyelitis is unclear. The SdrC protein facilitates Staphylococcus aureus adhesion and colonization, thereby promoting subsequent biofilm accumulation and contributing to the progression of osteomyelitis. The role of SdrC, an important protein in S. aureus, in the progression of S. aureus-induced osteomyelitis requires further elucidation. Thus, we aimed to determine whether targeting SdrC is a novel strategy for treating S. aureus-induced osteomyelitis. The sdrC sequence of S. aureus was knocked out, and rat models with wild-type and sdrC knockout (KO) S. aureus-induced osteomyelitis were established. Enzyme-linked immunosorbent assays (ELISAs) were used to identify differences in the levels of the inflammatory factors IL-6 and TNF-α, and qPCR and Western blotting were used to identify changes in the levels of osteogenic indicators, such as ALP, OST and Runx2; these experiments analyzed the role of SdrC in the progression of S. aureus-induced osteomyelitis. Transcriptomic sequencing was used to explore the mechanism by which SdrC promotes the development of S. aureus-induced osteomyelitis at the molecular level. After the SdrC protein of S. aureus was knocked out, biofilm formation significantly decreased. Compared with the control group, The sdrC-KO osteomyelitis group showed milder bone tissue inflammation compared to the control group, and the expression of the inflammatory factors IL-6 and TNF-α decreased significantly (p < 0.05), whereas the expression of the osteogenic indicators ALP, OST, and Runx2 increased significantly, as shown by qPCR and Western blotting (p < 0.05). Alkaline phosphatase and alizarin red staining showed that knocking out SdrC increased ossification in rats and improved their prognosis. Transcriptomic sequencing revealed that Myh7 was significantly overexpressed in the sdrC-KO rats with osteomyelitis (p < 0.05). Knocking out Myh7 significantly reduced the mRNA and protein levels of osteogenic markers Runx2, ALP, Osterix (OSX), and osteocalcin (p < 0.05), suggesting that Myh7 inhibits the function of the S. aureus SdrC protein. The SdrC protein in S. aureus promotes the malignant progression of osteomyelitis and exacerbates the development of osteomyelitis by promoting S. aureus biofilms. Moreover, Myh7 hinders the ability of SdrC to promote biofilm formation, reducing the progression of osteomyelitis; these findings suggest that targeting SdrC or enhancing Myh7 expression could serve as a novel therapeutic strategyjbr osteomyelitis treatment.
Keywords: Staphylococcus aureus; Myh7; Osteomyelitis; SdrC protein.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethics approval and consent to participate: The animal experiment program was approved by the Medical Ethics Committee of the 920th Hospital of the PLA Joint Logistics Support Force [Approval No: Lunshen 2019–010 (Section) -01] and was carried out in accordance with the Guidelines for the Care and Use of Experimental Animals.
Similar articles
-
The ability of sarA to limit protease production plays a key role in the pathogenesis of Staphylococcus aureus osteomyelitis irrespective of the functional status of agr.Infect Immun. 2025 Jan 31;93(1):e0047324. doi: 10.1128/iai.00473-24. Epub 2024 Nov 29. Infect Immun. 2025. PMID: 39611695 Free PMC article.
-
RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis.Bone. 2024 Oct;187:117181. doi: 10.1016/j.bone.2024.117181. Epub 2024 Jul 1. Bone. 2024. PMID: 38960295
-
Overexpression of Agr quorum sensing system in uropathogenic Staphylococcus aureus in response to simulated urinary metabolic conditions enhancing growth and virulence.Med Microbiol Immunol. 2025 Aug 5;214(1):35. doi: 10.1007/s00430-025-00830-6. Med Microbiol Immunol. 2025. PMID: 40762857
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Ahmad-Mansour N, Loubet P, Pouget C, Dunyach-Remy C, Sotto A, Lavigne JP, Molle V (2021) Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins 13(10):677. https://doi.org/10.3390/toxins13100677 - PubMed - PMC
-
- Alvares PA, Mimica MJ (2020) Osteoarticular infections in pediatrics. Jornal De Pediatria 96:58–64. https://doi.org/10.1016/j.jped.2019.10.005 - PubMed
-
- Becker RE, Bubeck Wardenburg J (2015) Staphylococcus aureus and the skin: a longstanding and complex interaction. Skinmed 13(2):111–119 - PubMed
-
- Berni F et al (2020) Synthetic carbohydrate-based cell wall components from Staphylococcus aureus. Drug Discov Today Technol 38:35–43 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials